| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/14/2011 | CN101327266B Oral cavity nursing agent for preventing and treating oral disease induced by Helicobacter pylori infection contamination |
| 09/14/2011 | CN101284870B Polypeptides of anti-measles virus and human immunodeficiency virus and use |
| 09/14/2011 | CN101244075B Application of astragaloside in preparing anti-hepatitis B virus medicaments |
| 09/14/2011 | CN101229223B Applications of fructus psoraleae extractive on preparing antitumor medicines |
| 09/14/2011 | CN101210012B Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 09/14/2011 | CN101204399B External medicine for tinea pedis |
| 09/14/2011 | CN101194969B Fumigation medicament for treating dermatophytosis |
| 09/14/2011 | CN101186637B Method for inhibiting influenza virus infection and medicament thereof |
| 09/14/2011 | CN101163788B Skin treatment compositions |
| 09/13/2011 | US8019557 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/13/2011 | US8017753 Mycobacterial antigens expressed under low oxygen tension |
| 09/13/2011 | US8017749 Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
| 09/13/2011 | US8017733 Covalent attachment of hydrophilic polymers, such as polyalkylene glycol polymers, also known as polyalkylene oxides, to biologically-active molecules |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017599 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 09/13/2011 | US8017596 Phosphonates useful as modulators of T-γ-9-δ-2 activity |
| 09/13/2011 | US8017574 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis |
| 09/13/2011 | US8017317 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 09/13/2011 | US8017134 Recombinant toxin fragments |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | CA2619077C Methods for the preparation of hcv polymerase inhibitors |
| 09/13/2011 | CA2615921C Hepatitis c inhibitor peptide analogs with a quinoline or a thienopyridine moiety |
| 09/13/2011 | CA2492410C Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 09/13/2011 | CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/13/2011 | CA2356836C Novel streptococcus antigens |
| 09/13/2011 | CA2351735C Engineered cytotoxic ribonuclease |
| 09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
| 09/13/2011 | CA2220964C Alphavirus rna replicon systems |
| 09/13/2011 | CA2187535C Borrelia burgdorferi bacterin |
| 09/09/2011 | WO2011109471A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | WO2011108999A1 Vaccines and vaccine compositions, and methods for the manufacture thereof |
| 09/09/2011 | WO2011108785A1 Peptide compound having inhibitory activity for infection or proliferation of orientia tsutsugamushi, and pharmaceutical composition for relieving scrub typhus using same |
| 09/09/2011 | WO2011108624A1 Polymer of nitrogen-containing compound, method for producing same, and gene transfer agent |
| 09/09/2011 | WO2011108521A1 Mucosal vaccine |
| 09/09/2011 | WO2011108471A1 Virus inhibitor |
| 09/09/2011 | WO2011108275A1 Immunoglobulin a secretion promoter |
| 09/09/2011 | WO2011107989A1 Improved therapeutic antibodies against flagellated pseudomonas aeruginosa |
| 09/09/2011 | WO2011107019A1 Antibacterial compounds, preparation methods and uses thereof |
| 09/09/2011 | WO2011106993A1 Gold nanoparticles modified by aminopyrimide, preparation method and use thereof |
| 09/09/2011 | WO2011106992A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 09/09/2011 | WO2011106986A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 09/09/2011 | WO2011106929A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 09/09/2011 | WO2011106882A1 Target of egr1 (toe1 ) polypeptides for inhibition of hiv |
| 09/09/2011 | WO2011106858A1 Fast-dissolving solid pharmaceutical form for treating bacterial infections |
| 09/09/2011 | WO2011086577A3 Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts |
| 09/09/2011 | WO2011073112A3 Mannose derivatives as antagonists of bacterial adhesion |
| 09/09/2011 | WO2011057145A3 Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same |
| 09/09/2011 | WO2011056630A3 Small molecule inhibitors of hepatitis c virus |
| 09/09/2011 | WO2011050196A9 Method for treating herpes virus infection |
| 09/09/2011 | WO2011049987A3 Azaindazoles to treat flaviviridae virus infection |
| 09/09/2011 | WO2010132759A9 Antibacterial derivatives of dibekacin |
| 09/09/2011 | WO2008151041A3 Materials and methods for preparation of alkaline earth ferrates from alkaline earth oxides, peroxides, and nitrates |
| 09/09/2011 | CA2792003A1 Compositions comprising myristic acid and uses thereof |
| 09/09/2011 | CA2791884A1 Compositions and methods for treating viral diseases |
| 09/09/2011 | CA2791850A1 Molecular clone of hiv-1 |
| 09/09/2011 | CA2791676A1 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 09/09/2011 | CA2791661A1 Mucosal vaccines |
| 09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | CA2791630A1 Combination pharmaceutical agents as inhibitors of hcv replication |
| 09/09/2011 | CA2791426A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 09/09/2011 | CA2789480A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 09/09/2011 | CA2787123A1 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 09/08/2011 | US20110218506 Amorolfine patch for the treatment of onychomycosis |
| 09/08/2011 | US20110218250 Composition based on glycerol ether/polyol mixtures |
| 09/08/2011 | US20110218241 Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
| 09/08/2011 | US20110218239 Use of 5,6-Dimethylxanthenone-4-Acetic Acid as an Antiviral Agent |
| 09/08/2011 | US20110218226 Anti-virulence compositions and methods |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218220 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| 09/08/2011 | US20110218204 Pharmaceutically acceptable salts of novel betulinic acid derivatives |
| 09/08/2011 | US20110218195 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 09/08/2011 | US20110218194 Heterocyclic aspartyl protease inhibitors |
| 09/08/2011 | US20110218186 Spirocyclic heterocyclic derivatives and methods of their use |
| 09/08/2011 | US20110218180 Esters of Capsaicin for Treating Pain |
| 09/08/2011 | US20110218175 Antiviral agents |
| 09/08/2011 | US20110218173 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives |
| 09/08/2011 | US20110218171 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/08/2011 | US20110218169 Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia |
| 09/08/2011 | US20110218168 Substituted polyamines as inhibitors of bacterial efflux pumps |
| 09/08/2011 | US20110218166 Mucoadherents compositions and their use |
| 09/08/2011 | US20110218162 15-thia steroid compounds and compositions |
| 09/08/2011 | US20110218158 Dna cytosine deaminase inhibitors |
| 09/08/2011 | US20110218157 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 09/08/2011 | US20110218140 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| 09/08/2011 | US20110218139 Combination therapy and methods for treating bacterial biofilms |
| 09/08/2011 | US20110218138 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 09/08/2011 | US20110217749 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 09/08/2011 | US20110217394 Iridoid Based Formulations |
| 09/08/2011 | US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/08/2011 | US20110217375 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 09/08/2011 | US20110217367 Means for inhibiting the expression of orc-1 |
| 09/08/2011 | US20110217366 Immunopotentiating composition |
| 09/08/2011 | US20110217364 Conjugated suramin amino compounds for medical conditions |
| 09/08/2011 | US20110217362 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217360 Octenidine composition |
| 09/08/2011 | US20110217359 Pharmaceutical composition for the prophylactic or therapeutic treatment of decubiti and first degree burns and treatment method |
| 09/08/2011 | US20110217344 Spermicidal and virucidal properties of various forms of sophorolipids |